Axon Enterprise earnings analysis: questions answered and next catalysts

Axon Enterprise (AXON) shares closed at $312.79 on November 6, marking a 18.24% decline and hitting a 52-week low ($307.00–$665.07). The company's market capitalization stands at approximately $25.3 billion. The Nasdaq, meanwhile, gained 1.7% on the same day, suggesting a company-specific reaction rather than a broader market trend.

Q3 FY2026 financial results were disclosed on November 5. The earnings per share (EPS) of $1.72 fell short of the estimated $1.91, representing a 9.95% decrease. Revenue for the quarter amounted to $908.55 million, up 28% year-over-year, compared to the estimated $940.02 million. In the same period, Piper Sandler analysts deemed Axon's Q3 as one of its worst quarters since going public.

For Q3, Axon Enterprise reported an EPS of $1.72 against an estimated $1.91, while revenue hit $908.55 million, surpassing the $940.02 million forecast. However, these figures marked a notable downturn in performance for the company. Analysts predict Q4 earnings per share at $2.28 and revenue of $1.06 billion, though such projections remain subject to change.

Bullish sentiment highlights delays as timing issues rather than lost deals, with software growth accelerating and the stock down by about 46% year-to-date. Conversely, bears point to guidance cuts, hardware margin pressures, and a week-long 27% drop in the stock price. Despite guidance adjustments, Axon's consensus FY2027 EPS estimate is $10.57 (up from $7.68 in FY2026). Even so, consensus estimates have not been revised downward, with a minimal 0.83% increase in 30-day EPS revision.

Current stock figures are intraday and subject to fluctuation, while consensus data originates from the earnings overview with analyst commentary dated November 6, 2026. This report, a blend of AI-generated insights and editorial review, emphasizes the company-specific issues impacting Axon Enterprise's stock performance.